Dianthus Therapeutics
DNTH
DNTH
93 hedge funds and large institutions have $276M invested in Dianthus Therapeutics in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 19 closing their positions.
Holders
93
Holders Change
-4
Holders Change %
-4.12%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
30
Reduced
24
Closed
19
Calls
$86K
Puts
–
Net Calls
+$86K
Net Calls Change
+$85K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$221K | -1,410 | Closed |
|
102
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$201K | -1,288 | Closed |
|
103
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$193K | -1,234 | Closed |
|
104
Marshall Wace
London,
United Kingdom
| – | -$146K | -936 | Closed |
|
105
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$128K | -818 | Closed |
|
|
RJA
106
Raymond James & Associates
St Petersburg,
Florida
| – | -$110K | -700 | Closed |
|
|
PMAM
107
Penn Mutual Asset Management
Conshohocken,
Pennsylvania
| – | -$89K | -572 | Closed |
|
|
PAM
108
Panagora Asset Management
Boston,
Massachusetts
| – | -$6K | -35 | Closed |
|
|
AF
109
Advisornet Financial
Minnetonka,
Minnesota
| – | -$1K | -6 | Closed |
|